Skip to main content
Caplight Logo









Olive Diagnostics

Olive Diagnostics

Private
JerusalemHealthcare & Life Scienceshttps://olivesensing.com

Last Round

Strategic

Mar 9, 2023

Total Funding Raised

$13.1M

Company Overview

Olive Diagnostics is a healthtech company that has developed a passive, non-invasive urinalysis sensor designed for real-time health monitoring and early disease detection.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

urinalysis sensorsmart toilethealth IoTremote patient monitoringIoMTgeriatric care technologypassive health monitoringHardware-as-a-ServiceHaaSclinical analyticsnon-invasive diagnosticsdigital healthchronic disease managementambient sensingtelemedicine hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Olive Diagnostics Comparables

Compare Olive Diagnostics with similar companies based on industry and business-model similarity.

Olive Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Starling Medical
89%
Metabowlite, Inc.
86%
Toi Labs
86%

Olive Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 9, 2023
AcceleratorJan 16, 2023
SeedSep 4, 2022
SeedFeb 1, 2022

Olive Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2022

    $5.8M raised from Amgen Ventures and eHealth Ventures.

Olive Diagnostics Filings

Explore SEC and related filing metadata, where available.

Olive Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Olive Diagnostics's valuation, stock price, and market status.

Is Olive Diagnostics a public or private company?

Olive Diagnostics is a private company.

What is the current stock price of Olive Diagnostics?

Olive Diagnostics is a private company, so its shares have no public market price. Caplight tracks Olive Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Olive Diagnostics worth (valuation)?

Valuation information for Olive Diagnostics is not publicly available.

Can I buy Olive Diagnostics stock?

Olive Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Olive Diagnostics's last funding round?

Olive Diagnostics's most recent funding round was Strategic on March 9, 2023.

Who are the main investors in Olive Diagnostics?

Key investors in Olive Diagnostics include Google for Startups Growth Academy: AI for Health, Israel Innovation Authority, eHealth Ventures, Amgen Ventures.

Will Olive Diagnostics IPO soon?

No public IPO plans have been announced for Olive Diagnostics.

How can I track Olive Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades in Olive Diagnostics's shares on secondary markets.

Firmographic Details

HeadquartersJerusalem
Employee Range18
Year Founded2019
Last FundingMar 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?